Someone should ask AMBS that question. I can see it becoming an issue in future months/years on MBs like this if there's any uncertainty about AMBS benefiting from MANF vs. competitors.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links